Tualatin, Oregon Clinical Trials

A listing of Tualatin, Oregon clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

total body irradiation
shake
nitrosourea
nervous system
radiopharmaceutical
Oregon Health and Science University
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
None

Providence Portland Medical Center
 (8.4 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

Providence Portland Medical Center
 (8.4 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations
Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy

The objective of this proposal is to investigate the effect of non-invasive repetitive cerebellar transcranial magnetic stimulation (rTMS) on motor control in progressive supranuclear (PSP). The central hypothesis is that augmenting cerebellar inhibition via cerebellar rTMS will decrease postural instability in patients with PSP by increasing functional connectivity between the …

progressive supranuclear palsy
transcranial magnetic stimulation
speech therapy
dopamine
Oregon Health & Science University
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Clinical and Genetic Analysis of ROP

Retinopathy of Prematurity (ROP) is a vascular disease affecting the retinas (back of the eye) of low birth weight infants. Although it can be treated effectively if diagnosed early, it continues to be a leading cause of childhood blindness in the United States and throughout the world. The investigators feel …

strabismus
retinopathy
vascular disease
pediatric
genetic analysis
Oregon Health & Science University
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

deficiency
gaucher disease
eliglustat
imiglucerase
Investigational Site Number 840080
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +220 other locations
Mucopolysaccharidosis I (MPS I) Registry

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients …

Investigational Site Number 840080
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +135 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

glycogen storage disease type ii
myozyme
gaa gene
deficiency
replacement therapy
Investigational Site Number 840080
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +190 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

modafinil
genetic testing
methyldopa
alpha-synuclein
bradykinesia
Oregon Health &Science University
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +45 other locations
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

This trial collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, prevent, and treat these side effects.

biospecimen collection
Providence Saint Vincent Medical Center
 (8.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +380 other locations